So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

So-Young International Inc.NASDAQ: SY

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin growth accelerates

Q1 FY2026 selling, general & admin of CN¥214.03M rose 36.2% year over year, ahead of the +17.1% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 19.8% from the prior quarter. Over 3 fiscal years it compounded at +4.4% a year.

Context

  • Selling, general & admin amounted to 56.3% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Selling, general & admin increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 2 analysts of CN¥1.18B (+41.5%) for the fiscal year ending Dec 2026, a step up from the +1.9% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CN¥214.03M-19.8% QoQ
Last fiscal yearDec 2025
CN¥833.76M+1.9% YoY
LTMMar 2026
CN¥910.25M+17.1% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.2%+30.2%-6.0 pp
1 year+1.9%+41.5%+39.6 pp
3-year CAGR+4.4%+36.0%+31.5 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

CNY · from the income statement

Latest · FY2025
833.76M CNY
Year-over-year change
+1.9%
4-year CAGR
-5.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +17.1% is the 3rd highest of 11, against a peer median of -5.8%.
  • Selling, general & admin amounts to 55.2% of revenue for SY, versus a peer median of 76.9%.
SY Competitors
Selling, General & Admin for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYSo-Young International Inc.LTM Mar 2026CN¥910.25M CNY+17.1%+4.4%55.2%
VREXVarex Imaging CorporationLTM Apr 2026$135.6M USD-0.5%+4.1%15.8%
LABStandard BioTools Inc.LTM Mar 2026$97.69M USD-22.9%+2.4%113.3%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$91.67M USD+21.1%+0.4%112.9%
ADCTADC Therapeutics S.A.LTM Mar 2026$82.03M USD+32.5%—103.6%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$55.57M USD-17.1%+24.5%—
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$52.28M USD-5.2%+10.5%—
SNDASonida Senior Living, Inc.LTM Mar 2026$41.84M USD+2.6%+9.6%10.2%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026$34.94M USD-61.3%—50.2%
OMEROmeros CorporationLTM Mar 2026$33.4M USD-31.3%-6.4%337.6%
SLPSimulations Plus, Inc.LTM Feb 2026$30.57M USD-6.4%+9.6%38.0%
Peer median (excluding SY) —-5.8%+6.8%76.9%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.